NORA MAHONEY: Open Payments
NPI 1558996975 · AMHERST, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 45 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $548 · 2025 $1,019
Food & beverage: $930Education: $89
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 8 | $191 |
| Actelion Pharmaceuticals US, Inc. | 5 | $180 |
| Amgen Inc. | 9 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $131 |
| PFIZER INC. | 3 | $77 |
| HARMONY BIOSCIENCES LLC | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Edwards Lifesciences Corporation | 1 | $26 |
Products named: Attruby, Repatha, JARDIANCE, OPSUMIT, VYNDAQEL, WAKIX, OPSYNVI, AMVUTTRA.
Industry payments across MA — which companies pay providers there.
